Suppr超能文献

促肾上腺皮质激素释放因子结合蛋白“配体抑制剂”在大鼠脑中的反常激活作用

Paradoxical activational effects of a corticotropin-releasing factor-binding protein "ligand inhibitor" in rat brain.

作者信息

Chan R K, Vale W W, Sawchenko P E

机构信息

Laboratory of Neuronal Structure and Function, The Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA 92037, USA.

出版信息

Neuroscience. 2000;101(1):115-29. doi: 10.1016/s0306-4522(00)00322-5.

Abstract

The corticotropin-releasing factor-binding protein is distinct from known corticotropin-releasing factor receptors, but can bind the peptide and neutralize its biological actions. Recent interest has centered about the therapeutic potential of "ligand inhibitors" of binding protein action, synthetic corticotropin-releasing factor fragments which are inactive at corticotropin-releasing factor receptors, but can displace the peptide from the binding protein, thereby increasing levels of free corticotropin-releasing factor. To identify sites of action of such ligands, the distribution of Fos expression seen following intracerebroventricular administration of rat/human corticotropin-releasing factor(6-33) (5-50 microg) was charted in relation to corticotropin-releasing factor-binding protein and receptor expression. It was expected that Fos induction would mimic aspects of the distribution of the two known corticotropin-releasing factor receptors, but the far greater correspondence was seen with that of the binding protein itself. This included neurons in the isocortex, the olfactory system, amygdala and a number of discrete brainstem cell groups; many Fos-immunoreactive neurons in each were found to co-express corticotropin-releasing factor-binding protein messenger RNA. Subsets of activated neurons co-expressed Type 1 corticotropin-releasing factor receptor messenger RNA, though these were largely limited to cell groups that also express the corticotropin-releasing factor-binding protein, and where binding protein immunoreactivity and Type 1 receptor transcripts were found to co-exist. Responsive neurons displaying Type 2 corticotropin-releasing factor receptor message were seen reliably only in the lateral septal nucleus. These findings support only a limited capacity of the ligand inhibitor to activate neurons bearing corticotropin-releasing factor receptors. The more pervasive activation seen among neurons that express the corticotropin-releasing factor-binding protein may be indicative of an unexpected role for this protein in signaling by corticotropin-releasing factor-related peptides.

摘要

促肾上腺皮质激素释放因子结合蛋白不同于已知的促肾上腺皮质激素释放因子受体,但能结合该肽并中和其生物学作用。最近的研究兴趣集中在结合蛋白作用的“配体抑制剂”的治疗潜力上,即合成的促肾上腺皮质激素释放因子片段,它们在促肾上腺皮质激素释放因子受体上无活性,但能从结合蛋白上取代该肽,从而增加游离促肾上腺皮质激素释放因子的水平。为了确定此类配体的作用位点,绘制了脑室注射大鼠/人促肾上腺皮质激素释放因子(6 - 33)(5 - 50微克)后观察到的Fos表达分布与促肾上腺皮质激素释放因子结合蛋白和受体表达的关系。预期Fos诱导将模拟两种已知促肾上腺皮质激素释放因子受体分布的某些方面,但与结合蛋白本身的分布对应性更高。这包括大脑皮层、嗅觉系统、杏仁核中的神经元以及一些离散的脑干细胞群;发现每个区域中许多Fos免疫反应性神经元共表达促肾上腺皮质激素释放因子结合蛋白信使核糖核酸。活化神经元的亚群共表达1型促肾上腺皮质激素释放因子受体信使核糖核酸,尽管这些主要限于也表达促肾上腺皮质激素释放因子结合蛋白的细胞群,并且在这些细胞群中发现结合蛋白免疫反应性和1型受体转录本共存。仅在外侧隔核中可靠地观察到显示2型促肾上腺皮质激素释放因子受体信息的反应性神经元。这些发现仅支持配体抑制剂激活携带促肾上腺皮质激素释放因子受体的神经元的能力有限。在表达促肾上腺皮质激素释放因子结合蛋白的神经元中观察到的更普遍的激活可能表明该蛋白在促肾上腺皮质激素释放因子相关肽的信号传导中具有意想不到的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验